Literature DB >> 8214940

Arteriovenous differences in PCO2 and pH are good indicators of critical hypoperfusion.

H Zhang1, J L Vincent.   

Abstract

Recent reports have suggested that increases in venoarterial difference in PCO2 (VAPCO2) and arteriovenous difference in pH (AVpH) represent valuable markers of tissue hypoxia in shock states associated with low cardiac output. We compared the values of VAPCO2 and AVpH with that of blood lactate in their relationship to changes in O2 uptake (VO2) and O2 delivery (DO2) during an acute reduction in blood flow induced by cardiac tamponade. In 13 anesthetized and mechanically ventilated dogs, a catheter was inserted into the pericardium to inject saline and to measure the intrapericardial pressure. VO2 was derived from expired gas analysis. DO2 was calculated by the product of the thermodilution cardiac index and the arterial O2 content. The critical DO2 (DO2crit) was found at 9.9 +/- 1.8 ml/kg.min. VAPCO2 and AVpH, which were 7.1 +/- 4.6 mm Hg and 0.028 +/- 0.025 U, respectively, at baseline, progressively increased to reach 17.5 +/- 6.6 mm Hg and 0.114 +/- 0.054 U, respectively, at DO2crit (both p < 0.01). Below DO2crit they increased more dramatically. These changes were related to both arterial hypocapnia and mixed venous hypercapnia. CO2 excretion decreased from 5.8 +/- 2.0 ml/kg-min at baseline to 3.9 +/- 0.9 ml/kg.min at DO2crit (p < 0.01). End-tidal CO2 tension significantly fell below DO2crit. Lactate levels increased from 2.1 +/- 0.5 to 3.5 +/- 0.5 mmol/L at DO2crit (P < 0.01) and to 6.9 +/- 2.1 mmol/L (p < 0.01) at the end of the study. There was no statistically significant difference between the DO2crit calculated for VAPCO2, AVpH, lactate, or VO2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214940     DOI: 10.1164/ajrccm/148.4_Pt_1.867

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  30 in total

Review 1.  Monitoring CO2 in shock states.

Authors:  Pierre-Eric Danin; Nils Siegenthaler; Jacques Levraut; Gilles Bernardin; Jean Dellamonica; Karim Bendjelid
Journal:  J Clin Monit Comput       Date:  2014-11-13       Impact factor: 2.502

2.  Understanding the Haldane effect.

Authors:  Jean-Louis Teboul; Thomas Scheeren
Journal:  Intensive Care Med       Date:  2016-02-11       Impact factor: 17.440

3.  End-points of resuscitation: arterial blood pressure, oxygen delivery, blood lactate, or...?

Authors:  J L Vincent
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

4.  Venous-to-arterial carbon dioxide differences and the microcirculation in sepsis.

Authors:  Mui Teng Chua; Win Sen Kuan
Journal:  Ann Transl Med       Date:  2016-02

Review 5.  Tissue capnometry: does the answer lie under the tongue?

Authors:  Alexandre Toledo Maciel; Jacques Creteur; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-10-02       Impact factor: 17.440

6.  Nitric oxide-releasing xerogel-based fiber-optic pH sensors.

Authors:  Kevin P Dobmeier; Gregory W Charville; Mark H Schoenfisch
Journal:  Anal Chem       Date:  2006-11-01       Impact factor: 6.986

7.  Early jugular bulb oxygenation monitoring in comatose patients after an out-of-hospital cardiac arrest.

Authors:  J G van der Hoeven; J de Koning; E A Compier; A E Meinders
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 8.  Oxygen transport-the oxygen delivery controversy.

Authors:  Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

9.  Systemic and regional pCO2 gradients as markers of intestinal ischaemia.

Authors:  A Heino; J Hartikainen; M E Merasto; E Alhava; J Takala
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

10.  Using a human cardiovascular-respiratory model to characterize cardiac tamponade and pulsus paradoxus.

Authors:  Deepa Ramachandran; Chuan Luo; Tony S Ma; John W Clark
Journal:  Theor Biol Med Model       Date:  2009-08-06       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.